Nasal Vaccine
India approves nasal vaccine for COVID-19
Officials said the nasal vaccine has been approved for those aged above 18 years.
NEW DELHI: India’s federal government approved on Friday the use of intranasal COVID-19 vaccine iNCOVACC, officials said.
The nasal vaccine, manufactured by Bharat Biotech International Ltd., will be used as a heterologous booster.
“Nasal vaccines are currently only available in private hospitals,” reported India’s public service broadcaster Prasar Bharati News Services and Digital Platform.
Officials said the nasal vaccine has been approved for those aged above 18 years.
The vaccine received approval from the Drugs Controller General of India last month for restricted use in an emergency situation.
-Xinhua
Related News
